loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 21361 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 RIFAXIMIN (2)

filter

01 SALIX PHARMS (2)

filter

01 TABLET;ORAL (2)

filter

01 200MG (1)

02 550MG (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
550MG
XIFAXAN
USA
21361
2010-03-24
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
200MG
XIFAXAN
USA
21361
2004-05-25
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21361

Looking for CTD TGA MCC DOSSIER APPLICATION 21361 2

19

Salix Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RIFAXIMIN, with a corresponding application number 21361 and regulatory information .

proudly manufactured in the

approval since 2010-03-24

Salix Pharmaceuticals's XIFAXAN TABLET;ORAL, medication with 550MG of RIFAXIMIN.

18

Salix Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RIFAXIMIN, with a corresponding application number 21361 and regulatory information .

proudly manufactured in the

approval since 2004-05-25

Salix Pharmaceuticals's XIFAXAN TABLET;ORAL, medication with 200MG of RIFAXIMIN.

Post Enquiry
POST ENQUIRY